Design Therapeutics, Inc.
DSGN • NASDAQ • Stock Fundamentals
Design Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Pratik Shah, with a market cap of $657.7M.
Market Cap$657.7M
Employees57.0
CEOPratik Shah
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsApr 28, 2026 · 1 month 17 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Design Therapeutics, Inc. FAQ
Common questions about Design Therapeutics, Inc.
Design Therapeutics, Inc. (DSGN) has a market capitalization of $657.7M and trades on NASDAQ.
Design Therapeutics, Inc. has approximately 57 employees.